Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Neulasta (pegfilgrastim)
i
Other names:
KRN125, SD/01, KRN-125, KRN 125
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Amgen, Kyowa Kirin, Roche
Drug class:
G-CSF stimulant
Related drugs:
‹
Nugraf (filgrastim biosimilar) (3)
SV-BR-1-GM (2)
pegfilgrastim-jmdb (0)
GW003 (balugrastim biosimilar) (0)
lenograstim (0)
Lonquex (lipegfilgrastim biosimilar) (0)
MEDI5395 (0)
pegfilgrastim-apgf (0)
mecapegfilgrastim (0)
RP2 (0)
eflapegrastim-xnst (0)
G-CSF and polysialic acid (0)
pegfilgrastim-cbqv (0)
pegfilgrastim-bmez (0)
recombinant G-CSF (0)
Nugraf (filgrastim biosimilar) (3)
SV-BR-1-GM (2)
pegfilgrastim-jmdb (0)
GW003 (balugrastim biosimilar) (0)
lenograstim (0)
Lonquex (lipegfilgrastim biosimilar) (0)
MEDI5395 (0)
pegfilgrastim-apgf (0)
mecapegfilgrastim (0)
RP2 (0)
eflapegrastim-xnst (0)
G-CSF and polysialic acid (0)
pegfilgrastim-cbqv (0)
pegfilgrastim-bmez (0)
recombinant G-CSF (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
HER-2 negative
HER2 Negative Breast Cancer
HER-2 negative
HER2 Negative Breast Cancer
albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim
Sensitive: C3 – Early Trials
albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim
Sensitive
:
C3
albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim
Sensitive: C3 – Early Trials
albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login